Abstract
Introduction
Colonization with Group B Streptococcus in pregnancy is a major risk factor for neonatal infection. Universal screening for maternal streptococcal colonization and the use of intrapartum antibiotic prophylaxis has resulted in substantial reductions of neonatal early-onset Group B Streptococcus disease. To achieve the best neonatal outcomes, it is imperative for maternity healthcare providers to adhere to screening and management guidelines.
Aim
This literature review uses a systematic approach and aims to provide a synthesis of what is known about compliance with Group B Streptococcus screening protocols in a variety of global settings, including maternity homes, private obstetric practice, and hospital clinical environments.
Methods
The review was carried out using electronic databases as well as hand-searching of reference lists. Included papers reported primarily on compliance with Group B Streptococcus screening guidelines, potential factors which influence compliance rates, and implementations and outcomes of interventions.
Results
Six international studies have been retained which all focused on adherence to Group B Streptococcus screening guidelines and demonstrated that different factors might have an influence on adherence to GBS screening protocols such as financial aspects and high caesarean section rates. Findings of relatively low compliance rates led to recognizing the need of developing improved strategies for optimising antenatal GBS screening adherence.
Conclusion
Adhering to Group B Streptococcus screening guidelines to prevent neonatal infection is crucial. Various factors influence compliance rates such as financial aspects and high proportions of caesarean sections. The implementation of strategies and different forms of education can result in improved compliance rates.
Similar content being viewed by others
References
Arabi, Y. M., Al-Dorzi, H. M., Alamry, A., Hijazi, R. E., Alsolamy, S., Al Salamah, M., et al. (2017). The impact of a multifaceted intervention including sepsis electronic alert system and sepsis response team on the outcomes of patients with sepsis and septic shock. Annals of Intensive Care, 7(1), 57. https://doi.org/10.1186/s13613-017-0280-7.
Arditi, C., Rège-Walther, M., Durieux, P., & Burnand, B. (2017). Computer-generated reminders delivered on paper to healthcare professionals: effects on professional practice and healthcare outcomes. The Cochrane database of systematic reviews, 7(7), CD001175. https://doi.org/10.1002/14651858.CD001175.pub4.
Björklund, V., Nieminen, T., Ulander, V. M., Ahola, T., & Saxen, H. (2017). Replacing risk-based early-onset-disease prevention with intrapartum group B streptococcus PCR testing. The Journal of Maternal-Fetal & Neonatal Medicine, 30(3), 368–373. https://doi.org/10.3109/14767058.2016.1173030.
Burns, G., & Plumb, J. (2013). GBS public awareness, advocacy, and prevention–what’s working, what’s not and why we need a maternal GBS vaccine. Vaccine, 31(Suppl 4), D58–D65. https://doi.org/10.1016/j.vaccine.2013.02.039.
Carrillo-Ávila, J. A., Gutiérrez-Fernández, J., González-Espín, A. I., García-Triviño, E., & Giménez-Lirola, L. G. (2018). Comparison of qPCR and culture methods for group B Streptococcus colonization detection in pregnant women: Evaluation of a new qPCR assay. BMC Infectious Diseases, 18(1), 305. https://doi.org/10.1186/s12879-018-3208-4.
Centers for Disease Control and Prevention (CDC). (2018). Group B Strep (GBS). Retrieved from https://www.cdc.gov/groupbstrep/clinicians/clinical-overview.html
Clifford, V., Garland, S. M., & Grimwood, K. (2012). Prevention of neonatal group B streptococcus disease in the 21st century. Journal of Paediatrics and Child Health, 48(9), 808–815. https://doi.org/10.1111/j.1440-1754.2011.02203.x.
Gerolymatos, G., Karlovasiti, P., Sianou, A., Logothetis, E., Kaparos, G., Grigoriadis, C., & Baka, S. (2018). Antenatal group B streptococcus detection in pregnant women: Culture or PCR? The Journal of Infection in Developing Countries, 12(8), 631–635. https://doi.org/10.3855/jidc.10367.
Gopal Rao, G., Nartey, G., McAree, T., O’Reilly, A., Hiles, S., Lee, T., et al. (2017). Outcome of a screening programme for the prevention of neonatal invasive early-onset group B Streptococcus infection in a UK maternity unit: An observational study. British Medical Journal Open, 7(4), e014634–e014634. https://doi.org/10.1136/bmjopen-2016-014634.
Heath, P. T., & Jardine, L. A. (2014). Neonatal infections: Group B streptococcus. BMJ Clinical Evidence, 2014, 0323.
Helder, O. K., Brug, J., Looman, C. W., van Goudoever, J. B., & Kornelisse, R. F. (2010). The impact of an education program on hand hygiene compliance and nosocomial infection incidence in an urban neonatal intensive care unit: An intervention study with before and after comparison. International Journal of Nursing Studies, 47(10), 1245–1252. https://doi.org/10.1016/j.ijnurstu.2010.03.005.
Helmig, R. B., & Gertsen, J. B. (2017). Diagnostic accuracy of polymerase chain reaction for intrapartum detection of group B streptococcus colonization. Acta Obstetricia et Gynecologica Scandinavica, 96(9), 1070–1074. https://doi.org/10.1111/aogs.13169.
Higgins, & Green. (2011). Cochrane Handbook for Systematic Reviews of Interventions In Vol. Version 5.1.0. Retrieved from www.handbook.cochrane.org
Hoffmann, T., Bennett, S., & Del Mar, C. (2010). Evidence-based practice across the health professions. Chatswood, Australia: Melinda McEvoy.
JBI (2017). The Joanna Briggs Institute Critical Appraisal tools. Retrieved from https://joannabriggs.org/sites/default/files/2019-05/JBI_RCTs_Appraisal_tool2017_0.pdf
Khalil, M. R., Uldbjerg, N., Thorsen, P. B., & Moller, J. K. (2019). Risk-based approach versus culture-based screening for identification of group B streptococci among women in labor. International Journal of Gynaecology and Obstetrics, 144(2), 187–191. https://doi.org/10.1002/ijgo.12721.
Koppes, D. M., Vriends, A. A. C. M., van Rijn, M., & van Heesewijk, A. D. (2017). Clinical value of polymerase chain reaction in detecting group B Streptococcus during labor. Journal of Obstetrics and Gynaecology Research, 43(6), 996–1000. https://doi.org/10.1111/jog.13321.
Kunze, M., Zumstein, K., Markfeld-Erol, F., Elling, R., Lander, F., Prömpeler, H., et al. (2015). Comparison of pre- and intrapartum screening of group B streptococci and adherence to screening guidelines: A cohort study. European Journal of Pediatrics, 174(6), 827–835. https://doi.org/10.1007/s00431-015-2548-y.
Lamagni, T. L., Keshishian, C., Efstratiou, A., Guy, R., Henderson, K. L., Broughton, K., & Sheridan, E. (2013). Emerging trends in the epidemiology of invasive group B streptococcal disease in England and Wales, 1991–2010. Clinical Infectious Diseases, 57(5), 682–688. https://doi.org/10.1093/cid/cit337.
MacLaughlin, K., Garrison, G., Matthews, M., O’Brien, M., Westby, E., & Targonski, P. (2013). Increased adherence to prenatal group B streptococcal screening guidelines through a paired electronic reminder and education intervention. Maternal & Child Health Journal, 18(1), 16–21. https://doi.org/10.1007/s10995-013-1228-7.
Matsubara, K., Hoshina, K., Kondo, M., Miyairi, I., Yukitake, Y., Ito, Y., et al. (2017). Group B streptococcal disease in infants in the first year of life: a nationwide surveillance study in Japan, 2011–2015. Infection: A Journal of Infectious Diseases, 45(4), 449–458. https://doi.org/10.1007/s15010-017-0995-2.
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med, 6(7), 1000097.
Moorhead, R., Daley, A. J., Lee, L.-Y., Gorelik, A., & Garland, S. M. (2019). Compliance with screening for and recommended management of maternal group B streptococcus carriage in pregnancy. The Australian & New Zealand Journal Of Obstetrics & Gynaecology. https://doi.org/10.1111/ajo.12977.
Murray, Rosenthal, & Pfaller. (2016). Medical Microbiology (8th Edition ed.): Elsevier.
O’Sullivan, C. P., Lamagni, T., Patel, D., Efstratiou, A., Cunney, R., Meehan, M., et al. (2019). Group B streptococcal disease in UK and Irish infants younger than 90 days, 2014–15: A prospective surveillance study. The Lancet Infectious Diseases, 19(1), 83–90. https://doi.org/10.1016/S1473-3099(18)30555-3.
Picchiassi, E., Coata, G., Babucci, G., Giardina, I., Summa, V., Tarquini, F., et al. (2018). Intrapartum test for detection of Group B Streptococcus colonization during labor. The Journal of Maternal-Fetal & Neonatal Medicine, 31(24), 3293–3300. https://doi.org/10.1080/14767058.2017.1369041.
Plainvert, C., El Alaoui, F., Tazi, A., Joubrel, C., Anselem, O., Ballon, M., et al. (2018). Intrapartum group B Streptococcus screening in the labor ward by Xpert® GBS real-time PCR. European Journal of Clinical Microbiology & Infectious Diseases, 37(2), 265–270. https://doi.org/10.1007/s10096-017-3125-2.
RANZCOG. (2016). Maternal Group B Streptococcus in pregnancy: screening and management In: The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
Robertson-Malt, S. (2014). JBI’s systematic reviews: Presenting and interpreting findings. AJN The American Journal of Nursing, 114(8), 49–54. https://doi.org/10.1097/01.NAJ.0000453044.01124.59.
Shah, B. A., & Padbury, J. F. (2014). Neonatal sepsis. Virulence, 5(1), 170–178. https://doi.org/10.4161/viru.26906.
Silva, J. M., Stein, A. T., Schünemann, H. J., Bordin, R., Kuchenbecker, R., & de Lourdes Drachler, M. (2013). Academic detailing and adherence to guidelines for Group B streptococci prenatal screening: A randomized controlled trial. BMC Pregnancy Childbirth, 13, 68. https://doi.org/10.1186/1471-2393-13-68.
Singh, T., Barnes, E. H., & Isaacs, D. (2018). Early-onset neonatal infections in Australia and New Zealand, 2002–2012. Archives of Disease in Childhood Fetal and Neonatal Edition. https://doi.org/10.1136/archdischild-2017-314671.
Tanaka, K., Iwashita, M., Matsushima, M., Wachi, Y., Izawa, T., Sakai, K., & Kobayashi, Y. (2016). Intrapartum group B Streptococcus screening using real-time polymerase chain reaction in Japanese population. The Journal of Maternal-Fetal & Neonatal Medicine, 29(1), 130–134. https://doi.org/10.3109/14767058.2014.989496.
WHO. (2017, 6 November 2017). Immunizations, Vaccines and Biologicals. Retrieved from https://www.who.int/immunization/newsroom/press/news_group_b_strep_stillbirths_infant_deaths_2017/en/
Wollheim, C., Sperhacke, R. D., Fontana, S. K. R., Vanni, A. C., Kato, S. K., Araújo, P. R. D., et al. (2017). Group B Streptococcus detection in pregnant women via culture and PCR methods. Revista Da Sociedade Brasileira De Medicina Tropical, 50(2), 179–183. https://doi.org/10.1590/0037-8682-0454-2016.
Yamaguchi, K., & Ohashi, K. (2018). Management of group b streptococcus-positive pregnant women at maternity homes in JAPAN: A questionnaire survey of compliance among midwives. Maternal Health, Neonatology and Perinatology, 4(1), 4. https://doi.org/10.1186/s40748-017-0069-6.
Yeh, J. S., Van Hoof, T. J., & Fischer, M. A. (2016). Key features of academic detailing: Development of an expert consensus using the delphi method. American Health & Drug Benefits, 9(1), 42–50.
Author information
Authors and Affiliations
Contributions
SP, SG and DS performed the systemic review and substantially contributed to the conception and design of this study; all authors were involved in drafting the manuscript and revising it critically and supervised the whole review process. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pangerl, S., Sundin, D. & Geraghty, S. Group B Streptococcus Screening Guidelines in Pregnancy: A Critical Review of Compliance. Matern Child Health J 25, 257–267 (2021). https://doi.org/10.1007/s10995-020-03113-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10995-020-03113-z